Market OutlookEnergy & Infrastructure24 pages
Q2 2026 Energy & Infrastructure M&A Outlook
Deal velocity, valuation benchmarks, and capital availability across power, renewables, and midstream assets in North America and the Middle East.
Research Reports
Perspectives you can take into the room.
Periodic PDF reports on markets, sectors, and capital formation — structured for boards, sponsors, and institutional investors.
Each report examines a specific segment of the growth-stage capital markets. Our team updates facts, data, and transaction observations as conditions move so the version published here reflects our current view. The latest edition of each report appears below, with a brief overview of its contents. For institutional and professional use only.
Capital Markets ReviewCross-Sector18 pages
H1 2026 Middle Market Capital Markets Review
A structured review of raise activity, pricing dynamics, and investor positioning across growth equity, private credit, and structured capital.
Sector PrimerTechnology & Life Sciences20 pages
2026 Biotech & Life Sciences Financing Landscape
How growth-stage biotech and deep-tech companies are positioning for institutional capital across venture crossover, strategic capital, and project finance.
Sector PrimerTechnology & Life Sciences16 pages
Healthcare AI Equity Trajectory: 2026 Sector Review
How growth-stage healthcare AI companies are positioning for institutional capital — reimbursement clarity, clinical validation, and enterprise distribution as the new underwriting baseline.
Sector PrimerCross-Sector14 pages
Founder Liquidity Without IPO: Secondary & Tender Structures
A practical primer on secondary tenders, company-sponsored repurchases, and structured liquidity — when they work, how they are priced, and what boards should prepare.
Reports are published for general information only and do not constitute investment, legal, or tax advice, or an offer of services. For questions on our capabilities, please contact our team.